The Los Angeles area is seeing a troubling increase in local dengue fever cases, health officials warned Wednesday.

Summit Therapeutics' ivonescimab poised for FDA approval, with the potential to disrupt the oncology market. Read more on ...

After hours: September 17 at 7:44 PM EDT Loading Chart for AFMD ...

Eliminating fake vaccine news with pharmacist, nurse, and physician review. GSK plc recently announced topline Phase 3 clinical trial data for a combination regimen of two of its vaccines: the RSV ...

Its lead candidate, MK-6070, is a T-cell engager targeting delta-like ligand 3, an inhibitory canonical Notch ligand. Its lead candidate, Restoret, is an investigational, potentially first-in-class ...

Two Oral Presentations Featured Updated Ivonescimab Data from Phase II Studies in CRC and TNBC in Addition to Poster ...